IGC Pharma (IGC) announced that the Company’s recently appointed advisors entered into a Share Purchase Agreement on April 21, 2025, for the ...

BERLIN--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by ...

BERLIN, April 10, 2025--(BUSINESS WIRE)--Regulatory News: TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of ...

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for treatment of cancer by targeting the tumor microenvironment (TME ...

Aurobindo Pharma's Bone Treatment Drug Shows Promise in Tests Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has announced successful trial results for its new bone treatment medicine. The drug, ...

President Donald Trump said Tuesday that his administration will soon impose tariffs on pharmaceuticals coming from foreign countries, predicting drug companies will move their operations to the U.S..

April 9 (UPI) --Pharmaceuticals produced in China could become costlier after President Donald Trump announced his intention to impose a "major tariff on pharmaceuticals." Trump said he would ...

The U.S. President said he will “very shortly” announce a “major tariff” on pharmaceuticals, keeping up his criticism of China and other countries with large trade surpluses with the U.S. “Right now, ...

US President Donald Trump, on Wednesday, said his administration would soon announce a “major” tariff on pharmaceutical imports, aimed at encouraging drug manufacturers to shift operations ...

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...

Donald Trump says he will impose a pharmaceutical tariff, but there are no details yet A Morgan Stanley report identifies 31 global life sciences trading below – or close to – net cash backing ...

Royalty Pharma (RPRX) announced the appointment of Vlad Coric to the company’s board of directors, effective immediately. Vlad Coric is the chairman and CEO of Biohaven (BHVN). Published first ...